Keywords: medarex, begins, ipilimumab, cancer, trials, new, jersey

Medarex begins ipilimumab cancer trials

Article | 03 April 2006

Print This

New Jersey, USA-headquartered Medarex says it has begun a registrational clinical trial of ipilimumab (MDX-010) used as a monotherapy for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in